For example, Abukiwan et al. suggested that inhibition of miR-132-3p drove progression of pancreatic cancer [39]; miR-133a-5p was also found to function as a tumor suppressor in pancreatic cancer [40,41]; the group of Wang Lihua showed that miR-29b-3p decreased proliferation and mobility of pancreatic cancer by targeting SOX12 and DNMT3b [42]. Here, SOX12 is linked to familial pancreatic carcinoma.